All the articles, reviews and communications published in ActaBiomed go through the peer-review process and receive the reviewers reports. The Editor-in-Chief will communicate any decision to the corresponding author regarding the following:

  • Accept in Present Form: The manuscript is sent to production and published on
  • Accept after minor modification: The paper is in principle accepted after revision based on the reviewer’s comments. Authors have 15 days to review their paper and to resubmit it. If all points have been sufficiently addressed by the authors, the paper will be accepted.
  • Reconsider after Major Revisions: The acceptance of the manuscript would depend on the revisions. The author needs to provide a point by point response or provide a rebuttal if some of the reviewer’s comments cannot be revised. Usually, only one round of major revisions is allowed. Authors will be asked to resubmit the revised paper within 30 days. The revised version will be returned to the reviewers for a further evaluation.
  • Reject and Encourage Resubmission: An article where additional data are needed to support the conclusions will be rejected and the authors will be encouraged to re-submit the paper once further information have been collected. If the authors choose to resubmit at a later date, this will be considered as  a new submission.
  • Reject: The article has serious flaws, makes no original contribution, and the paper is rejected with no offer of resubmission to the journal.
  • “Unsubmitted” Manuscript: The manuscript that has not been submitted following the ActaBiomed guidelines is rejected.  This does not preclude resubmission of a corrected manuscript and is unlikely to affect reviewer assessment and, eventually, editorial decision. Authors are encouraged to resubmit within 15 days a new updated version.